Sclerostin, Osteocytes, and Chronic Kidney Disease – Mineral Bone Disorder

E-ISSN： 1525-139x|28|6|578-586

ISSN： 0894-0959

Source： SEMINARS IN DIALYSIS, Vol.28, Iss.6, 2015-11, pp. : 578-586

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic Kidney Disease-Mineral and Bone Disorder KDIGO Guidelines

Nephron Clin Pract, Vol. 116, Iss. 1, 2010-05 ,pp. : c25-c26

Karger

Access to resources Recommend Favorite

Chronic kidney disease–mineral bone disorder: an update on the pathology and cranial manifestations

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 44, Iss. 4, 2015-04 ,pp. : 239-243

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronic Kidney Disease-Related Mineral and Bone Disorders

Nephron Clin Pract, Vol. 112, Iss. 3, 2009-04 ,pp. : c128-c136

Karger

Access to resources Recommend Favorite

Potential for Biomarkers of Chronic Kidney Disease-Mineral Bone Disorder to Improve Patient Care

Nephron Clin Pract, Vol. 124, Iss. 3-4, 2013-12 ,pp. : 141-150

Karger

Access to resources Recommend Favorite

Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease

By Manghat P. Fraser W. Wierzbicki A. Fogelman I. Goldsmith D. Hampson G.

Osteoporosis International, Vol. 21, Iss. 11, 2010-11 ,pp. : 1853-1861

Springer Publishing Company

Access to resources Recommend Favorite